Otonomy Announces Multiple Presentations at Society for Neuroscience Annual Meeting including OTO-413 Presentation Selected as “Hot Topic”

Back to Jobs

SAN DIEGO , Oct. 30, 2018 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced multiple presentations related to the company’s programs in hearing loss and tinnitus at the upcoming Society

Apply Now